Abstract:miRNAs play important roles in modulating gene expression in varying cellular processes and disease pathogenesis, including neurodegenerative diseases. Several miRNAs are expressed in the brain, control brain development and are identified as important biomarkers in the pathogenesis of motor-and neuro-cognitive diseases such as Alzheimer's (AD), Huntington's and Parkinson's diseases (PD) and amyotrophic lateral sclerosis. These remarkable miRNAs could be used as diagnostic markers and therapeutic targeting potential for many stressful and untreatable progressive neurodegenerative diseases. To modulate these miRNA activities, there are currently two strategies involved; first one is to therapeutically restore the suppressed miRNA level by miRNA mimics (agonist), and the other one is to inhibit miRNA function by using anti-miR (antagonist) to repress overactive miRNA function. However, RNAi-based therapeutics often faces <i>in vivo</i> instability because naked nucleic acids are subject to enzyme degradation before reaching the target sites. Therefore, an effective, safe and stable bio-responsive delivery system is necessary to protect the nucleic acids from serum degradation and assist their entrance to the cells. Since neuronal cells are non-regenerating, to design engineered miRNAs to be delivered to the central nervous system (CNS) for long term gene expression and knockdown is representing an enormous challenge for scientists. This article provides an insight summary on some of the innovative strategies employed to deliver miRNA into target cells. These viral and non-viral carrier systems hold promise in RNA therapy delivery for neurodegenerative diseases.

Development of Microrna-Based Therapeutics for Central Nervous System Diseases.

Research Progress of Micro Ribonucleic Acid in Cerebral Ischemia

Stem Cells in Central Nervous System Diseases: Promising Therapeutic Strategies.

Exosomal Mirnas in Central Nervous System Diseases: Biomarkers, Pathological Mediators, Protective Factors and Therapeutic Agents.

Functions of MicroRNA in Nervous System Regulation

Micrornas: Innovative Targets for Cerebral Ischemia and Stroke

Getting miRNA Therapeutics into the Target Cells for Neurodegenerative Diseases: A Mini-Review

MicroRNA-based Therapeutic Technologies

MicroRNAs Modulate Neuroinflammation after Intracerebral Hemorrhage: Prospects for New Therapy.

MicroRNAs Expression and Function in Cerebral Ischemia Reperfusion Injury

MicroRNA-21 Is a Versatile Regulator and Potential Treatment Target in Central Nervous System Disorders

Advances in MicroRNA Therapeutics: From Preclinical to Clinical Studies

Systemic delivery of microRNA for treatment of brain ischemia

The Roles of MicroRNAs in Stroke: Possible Therapeutic Targets

MicroRNAs in the Neural System

Role and Regulatory Mechanism of Microrna Mediated Neuroinflammation in Neuronal System Diseases

Advances in carrier-delivered small interfering RNA based therapeutics for treatment of neurodegenerative diseases

MicroRNAs as therapeutic targets in human diseases

MicroRNAs: protective regulators for neuron growth and development

Small Interfering RNAs and Antisense Oligonucleotides for Treatment of Neurological Diseases

MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases